Glaxo, Xenoport's drug gets FDA nod for new use
Linkedin

Glaxo, Xenoport's drug gets FDA nod for new use

Dhāka : Bangladesh | Jun 07, 2012 at 6:07 AM PDT
Source: BDNews24
XX XX
Views: Pending
 
Drugmaker XenoPort Inc and its partner GlaxoSmithKline Plc said the US health regulator approved their drug to treat shingles related nerve pain that may cause disability in some people. XenoPort will get a milestone payment of $10 million from Glaxo following first sales of the drug, Horizant, to... FULL ARTICLE AT BDNews24
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
Advertisement
 
Advertisement
 

More From Allvoices

 
Tap_logo_330_110_event
 


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.